Log In
Print
BCIQ
Print
Print this Print this
 

ACH-2684

  Manage Alerts
Collapse Summary General Information
Company Achillion Pharmaceuticals Inc.
DescriptionHCV NS3 protease inhibitor
Molecular Target HCV NS3 protease
Mechanism of ActionHCV NS3 protease inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat HCV infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today